To go from Real-World Imaging Data to Evidence, Medexprim builds on:
⁃ A proven ETL (extract, transform, load) solution: the Medexprim Suite™
⁃ An innovative new platform combining Real-World Imaging Data & strong analytics capabilities to provide evidence: the R-WiDE Platform
⁃ The integration of the European legal framework into our software workflow (GDPR compliance)
⁃ An expanding network of European academic Hospitals and international data partners
Medexprim Suite™ is our current solution already deployed in our network of European hospitals, which connects to the Picture Archiving & Communication System (PACS) and other data sources.
It is composed of two main modules:
It processes new incoming imaging and clinical information to feed and enrich an index (Indexa™). Enrichment examples are the extraction of diagnoses via Natural Language Processing of radiology reports, an organ recognition algorithm applied to images, or extraction of radiomics features.
It automates the preparation of de-identified datasets, from the cohort constitution through unique data mining capabilities, combining imaging and clinical features, to patient information, to data extraction, and to de-identification according to project-specific rules.
R-WiDE platform aims to consolidate, organize, structure and enrich imaging and contextual Real-World Data to generate regulatory-grade evidence.
It federates our network of data partners and provides strong analytics capabilities to deliver Evidence services to Biopharma.
The platform is interoperable with other platforms and automates federation and intermediation.
Similarly to the European H2020 Chaimeleon project, exemplary on an academic level, R-WiDE ambitions to be an industrialized platform for private / public collaboration for research.
Enabling secondary use of medical data by healthcare professionals and researchers is crucial to improve the quality of care and to accelerate research. However, it is our ethical and moral duty and responsibility to ensure that the rights and freedoms of individuals are safeguarded and that the legislative and regulatory provisions relating to patient privacy and data protection are duly respected. Therefore, Medexprim has set up a technical and contractual framework supervised by our Data Protection Officer.
Acting as a trustworthy third party, and as a Data Processor in the sense given by the GDPR, Medexprim can directly and securely handle the constitution of any imaging database (extraction, anonymization, verification of anonymization, etc.), with organizational and technical safeguards without having access at any time to data directly identifying the data subjects.
⁃ Our expanding network of hospitals is built through commercial data deals and software deals, as well as major H2020 collaborative research projects. We know how to form collaborative win-win relationships with hospitals and healthcare providers.
⁃ We have established a growing network of scale-up partners, such as Hospital Information System (HIS) and PACS providers, with global or local reach, and for whom our technology platform represents an add-on they can offer to their installed base.
⁃ We are developing a network of international Data partners, providing us with access to data in geographies where we are on our way (US, Asia) and enabling us to serve global data requests.